Compound Detail
CHEMBL3904602
LEROCICLIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL3904602 |
| Name | LEROCICLIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | YPJRHEKCFKOVRT-UHFFFAOYSA-N |
13
Targets
29
Activities
2
Assay Types
0
PK Parameters
13
Publications
4
Known Names
5
Indications
Molecular Properties
474.6
MW (Da)
3.50
ALogP
8
HBA
2
HBD
91.2
PSA (Ų)
0.60
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Breast Neoplasms Endometrial Neoplasms Carcinoma, Ductal Carcinoma, Non-Small-Cell Lung Lung Neoplasms
Activity Summary
IC50 23 meas. best 9.0
Kd 6 meas. best 9.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Serine/threonine-protein kinase Nek10 CHEMBL3108655 | Kd | 9.7 | 9.7 | 0.2 | 1 |
| NUAK family SNF1-like kinase 2 CHEMBL5698 | Kd | 9.15 | 9.15 | 0.7 | 1 |
| Cyclin-dependent kinase 4/cyclin D1 CHEMBL1907601 | IC50 | 9.0 | 8.985 | 1.0 | 2 |
| Cyclin-dependent kinase 4 CHEMBL331 | IC50 | 9.0 | 9.0 | 1.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 9.0 | 7.4533 | 1.0 | 12 |
| Cyclin-dependent kinase 2 CHEMBL301 | IC50 | 8.82 | 7.135 | 1.5 | 4 |
| Cyclin-dependent kinase 6 CHEMBL2508 | IC50 | 8.7 | 8.7 | 2.0 | 1 |
| Dual specificity protein kinase TTK CHEMBL3983 | Kd | 8.38 | 8.38 | 4.2 | 1 |
| CDK6/cyclin D3 CHEMBL2111448 | IC50 | 8.33 | 8.33 | 4.7 | 1 |
| Serine/threonine-protein kinase ULK2 CHEMBL5435 | Kd | 8.26 | 8.26 | 5.5 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | Kd | 8.19 | 7.925 | 6.5 | 2 |
| Cyclin-dependent kinase 9 CHEMBL3116 | IC50 | 7.55 | 7.55 | 28.0 | 1 |
| CDK9/Cyclin-H CHEMBL4523632 | IC50 | 6.55 | 6.55 | 280.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31477350 | 10.1016/j.bmcl.2019.126637 | Receptor-type tyrosine-protein kinase FLT3 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 35485642 | 10.1021/acs.jmedchem.1c02064 | Unchecked | 2 |
| 31477350 | 10.1016/j.bmcl.2019.126637 | Serine/threonine-protein kinase Nek10 | 1 |
| 31477350 | 10.1016/j.bmcl.2019.126637 | NUAK family SNF1-like kinase 2 | 1 |
| 31477350 | 10.1016/j.bmcl.2019.126637 | Dual specificity protein kinase TTK | 1 |
| 31477350 | 10.1016/j.bmcl.2019.126637 | Serine/threonine-protein kinase ULK2 | 1 |
| 31477350 | 10.1016/j.bmcl.2019.126637 | CDK9/Cyclin-H | 1 |
| 31477350 | 10.1016/j.bmcl.2019.126637 | Cyclin-dependent kinase 2/cyclin E1 | 1 |
| 31477350 | 10.1016/j.bmcl.2019.126637 | Cyclin-dependent kinase 4/cyclin D1 | 1 |
| 32707525 | 10.1016/j.ejmech.2020.112571 | Cyclin-dependent kinase 4 | 1 |
| 32707525 | 10.1016/j.ejmech.2020.112571 | Cyclin-dependent kinase 6 | 1 |
| 32707525 | 10.1016/j.ejmech.2020.112571 | Cyclin-dependent kinase 9 | 1 |
Data from ChEMBL 36 via Core Engine